These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12800720)

  • 1. Let's hear it for B players.
    DeLong TJ; Vijayaraghavan V
    Harv Bus Rev; 2003 Jun; 81(6):96-102, 137. PubMed ID: 12800720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risky business of hiring stars.
    Groysberg B; Nanda A; Nohria N
    Harv Bus Rev; 2004 May; 82(5):92-100, 151. PubMed ID: 15146739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing your leadership pipeline.
    Conger JA; Fulmer RM
    Harv Bus Rev; 2003 Dec; 81(12):76-84, 125. PubMed ID: 14712546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new game plan for C players.
    Axelrod B; Handfield-Jones H; Michaels E
    Harv Bus Rev; 2002 Jan; 80(1):80-8, 126. PubMed ID: 12964469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growing talent as if your business depended on it.
    Cohn JM; Khurana R; Reeves L
    Harv Bus Rev; 2005 Oct; 83(10):62-70, 155. PubMed ID: 16250625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to keep A players productive.
    Berglas S
    Harv Bus Rev; 2006 Sep; 84(9):104-12, 157. PubMed ID: 16967624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The curse of the superstar CEO.
    Khurana R
    Harv Bus Rev; 2002 Sep; 80(9):60-6, 125. PubMed ID: 12227147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Master of the house: Why a company should take control of its building projects.
    Thurm D
    Harv Bus Rev; 2005 Oct; 83(10):120-9, 158. PubMed ID: 16250630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The passive-aggressive organization.
    Kaplan RS; Norton DP
    Harv Bus Rev; 2005 Oct; 83(10):82-92, 157. PubMed ID: 16250627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making star teams out of star players.
    Mankins M; Bird A; Root J
    Harv Bus Rev; 2013; 91(1-2):74-8, 144. PubMed ID: 23390743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy as ecology.
    Iansiti M; Levien R
    Harv Bus Rev; 2004 Mar; 82(3):68-78, 126. PubMed ID: 15029791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are you picking the right leaders?
    Sorcher M; Brant J
    Harv Bus Rev; 2002 Feb; 80(2):78-85, 128. PubMed ID: 11894681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making the most of on-line recruiting.
    Cappelli P
    Harv Bus Rev; 2001 Mar; 79(3):139-46, 166. PubMed ID: 11246921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Back where we belong.
    Critelli MJ
    Harv Bus Rev; 2005 May; 83(5):47-54, 152. PubMed ID: 15929403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Execution without excuses. Interview by Thomas A. Stewart and Louise O'Brien.
    Dell M; Rollins K
    Harv Bus Rev; 2005 Mar; 83(3):102-11, 150. PubMed ID: 15768680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The five messages leaders must manage.
    Hamm J
    Harv Bus Rev; 2006 May; 84(5):114-23, 158. PubMed ID: 16649703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are you in with the in crowd?
    Kleiner A
    Harv Bus Rev; 2003 Jul; 81(7):86-92, 118. PubMed ID: 12858713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead for loyalty.
    Reichheld FF
    Harv Bus Rev; 2001; 79(7):76-84, 144. PubMed ID: 11447619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capitalizing on capabilities.
    Ulrich D; Smallwood N
    Harv Bus Rev; 2004 Jun; 82(6):119-27, 138. PubMed ID: 15202293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A time for growth: an interview with Amgen CEO Kevin Sharer. Interview by Paul Hemp.
    Sharer K
    Harv Bus Rev; 2004; 82(7-8):66-74, 186. PubMed ID: 15241953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.